Small Molecules

24 Jan 2007 Safety Monitoring Board Recommends Continuation of EntreMed's MKC-1 Phase 2 Breast Cancer Study
24 Jan 2007 Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)
24 Jan 2007 New results from the ESPRIT trial confirm that dipyridamole plus aspirin is the treatment of choice for preventing recurrent stroke
24 Jan 2007 Stiefel Laboratories Receives FDA Approval Of Olux-E (Clobetasol Propionate) Foam, 0.05% For Treatment Of Psoriasis And Eczema
23 Jan 2007 Inovelon(R) recieves Marketing Authorization Approval from European Commission
23 Jan 2007 FDA Grants Chelsea Therapeutics Orphan Drug Designation for Droxidopa
23 Jan 2007 Ortho Biotech Seeks FDA Approval for DOXIL(R) in Combination with VELCADE(R) to Treat Relapsed/Refractory Multiple Myeloma
23 Jan 2007 Sirion Therapeutics Initiates Enrollment of Phase III Clinical Trials for the Treatment of Inflammation Following Ocular Surgery
23 Jan 2007 Infinity and MedImmune Provide Update On Phase I GIST Trial for IPI-504, a Novel Hsp90 Inhibitor
23 Jan 2007 Shire licenses the North American rights for SPD754 (apricitabine) to Avexa Ltd
23 Jan 2007 MediciNova Initiates Phase II Clinical Trial for MN-305, a Novel Treatment for Insomnia
20 Jan 2007 S-1 Oral Anticancer Agent Improves Patients' Survival In Adjuvant Gastric Cancer Trial Versus Surgery Alone
20 Jan 2007 Pharmos Corporation Announces Clinical Data From Phase 2a Trial Of Cannabinor For Capsaicin-induced Pain; Drug Ineffective In Trial
20 Jan 2007 Penwest Begins Next Study in Development of Nalbuphine ER
20 Jan 2007 Bionovo Launches Pharmacokinetics Trial of Its Lead Menopause Drug Candidate, MF101
20 Jan 2007 Elbion AG Acquires Late-Stage Product Candidate From DrugAbuse Sciences, Inc. For Treatment Of Alcohol Dependence
19 Jan 2007 Alexza Completes Enrollment in AZ-004 Phase IIa Clinical Trial in Schizophrenic Patients with Acute Agitation
19 Jan 2007 Anesiva Announces Clinical Data From Phase 1 Trial of 1207
19 Jan 2007 Pfizer's Sutent is Granted Full Marketing Authorization for First-Line Use in Advanced Kidney Cancer in the European Union
18 Jan 2007 Genaera Corporation Announces Presentation Of Data On Trodusquemine Mechanism Of Action In Obesity
18 Jan 2007 Exforge(R) approved in Europe as powerful new blood pressure therapy combining two leading medications in a single pill
18 Jan 2007 Marketing Authorisation Granted for Tandemact (TM) (pioglitazone/glimepiride) for Type 2 Diabetes in Europe
18 Jan 2007 Barrier Therapeutics Announces Positive Phase 2a Data for Oral Hivenyl(TM) in the Treatment of Itch in Atopic Dermatitis
18 Jan 2007 Molecular Insight Pharmaceuticals, Inc. Acquires Malignant Melanoma Radiotherapeutic Drug Candidate From Bayer Schering Pharma
18 Jan 2007 Cipher Pharmaceuticals's Response To Approvable Letter For CIP-ISOTRETINOIN Accepted For Review By FDA

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top